Search results
The purpose of this document is to provide interested parties with draft part one guidance on a select set of topics for the Maximum Monthly Cap on Cost-Sharing Payments Program, which was established by section 11202 of the Inflation Reduction Act (IRA) (P.L. 117-169) and signed into law on August 16, 2022.
If you have limited income and resources, you may be eligible for the Part D Extra Help program. This prescription drug discount program for Medicare recipients can significantly reduce your prescription drug costs, including premiums, deductibles, and copayments.
If you have limited income and resources, you may be eligible for the Part D Extra Help program. This prescription drug discount program for Medicare recipients can significantly reduce your prescription drug costs, including premiums, deductibles, and copayments.
30 lis 2015 · Pharmacy and Retailer Prescription Drug Discount Programs. Discount drug cards offered through chain pharmacies for a small monthly premium provide discounts on a number of services, including prescription drugs. Individuals with a Part D plan may use a discount card, but the two drug programs operate independently of one another.
Call us at 1-800-MEDICARE (1-800-633-4227). TTY users can call 1-877-486-2048. We can tell you your level of Extra Help and help you get your costs fixed with the plan. You may be able to get some money back if you: Paid for prescriptions after you qualified for Extra Help. Aren’t in a Medicare drug plan.
Pharmaceutical Assistance Programs. Some pharmaceutical companies offer programs to help pay for medications for people enrolled in Medicare drug coverage (Part D). Find out whether there’s a Pharmaceutical Assistance Program that can lower prescription costs for the drugs you take.
Beginning January 1, 2025, discounts on certain applicable Part D drugs will be provided under the Manufacturer Discount Program, which is described above. The Medicare Coverage Gap Discount Program makes manufacturer discounts available to eligible Medicare beneficiaries receiving applicable drugs while in the coverage gap benefit phase.
